Mangoceuticals (MGRX) Accumulated Depreciation & Amortization (2023 - 2025)
Historic Accumulated Depreciation & Amortization for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $758.0.
- Mangoceuticals' Accumulated Depreciation & Amortization fell 9217.02% to $758.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $758.0, marking a year-over-year decrease of 9217.02%. This contributed to the annual value of $9936.0 for FY2024, which is 6007.87% down from last year.
- Per Mangoceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $758.0 for Q3 2025, which was down 9217.02% from $502.0 recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Accumulated Depreciation & Amortization ranged from a high of $24889.0 in Q4 2023 and a low of $250.0 during Q1 2025
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $6224.0 (2024), whereas its average is $8314.3.
- In the last 5 years, Mangoceuticals' Accumulated Depreciation & Amortization surged by 233.48% in 2024 and then plummeted by 9598.33% in 2025.
- Mangoceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $24889.0 in 2023, then plummeted by 60.08% to $9936.0 in 2024, then crashed by 92.37% to $758.0 in 2025.
- Its last three reported values are $758.0 in Q3 2025, $502.0 for Q2 2025, and $250.0 during Q1 2025.